{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_pJ4LDA","lastupdate":"2024-09-25T00:00:00.000Z","update_date":"2024-09-25T00:00:00.000Z","lastModified":"Sep 25, 2024","active":1,"confidence_score":89,"confidence_score_reason":"markets, external profiles, not claimed","urlname":"synvaccine","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$lYTlGquH3g75Il9klCzbtPomsTPKVanOJscPNfWoRiDWXxdECw6ytA","name":"SynVaccine","oneliner":"Design and Construction of Viral-based Products","registrar":"514942291","website":"https://www.synvaccine.com","careerspage":"","founded_month":7,"founded_year":2013,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"1-10","employees_exact":6,"patent":1,"raised":1756000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Syn Vaccine","Syn-Vaccine"],"about":"SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology. The company utilizes a multidisciplinary approach combining technologies, such as synthetic biology, virology, bio-informatics, engineering, and robotics, to make viruses that can be used to develop new vaccines.\r\n\r\nSynVaccine's technology enables the design and fabrication of viral genomes using a safety-focused design approach. The resulting viruses have the potential to overcome the limitations of those found in nature or developed through traditional technologies.\r\n\r\nSynVaccine was founded as part of Rad BioMed, an Israel-based evergreen family fund that invests in early-stage biomedical start-ups, and on the basis of commercialized research from Tel Aviv University and Weizmann Institute of Science led by Professor Tamir Tuller.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972376849387","country":null,"address":{"israeli":[{"id":"36eddd7b-00b4-4a9d-b9bd-d54ac0a4ee11","city":"Tel Aviv-Yafo","type":null,"address":"HaBarzel Street 27, Tel Aviv-Yafo, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"19cd9f4b-1e53-4b4a-b859-f350d5b3381b","date":"Nov 6, 2017","link":"http://www.globes.co.il/en/article-israeli-viral-vaccines-co-synvaccine-raises-17m-1001210612","source":"www.globes.co.il","visible":1,"analysis":{"tags":"vaccines, synthetic biology","company":"SynVaccine","layoffs":null,"summary":"Israeli startup SynVaccine, which develops vaccines based on synthetic biology, has raised $1.7 million. The company has developed a proprietary technology that identifies significant parts of viruses and develops vaccines for them. SynVaccine sees its future in building positive viruses that strengthen the immune systems activity. The companys list of investors includes Yehuda and Prof. Nava Zisapel, Sapir Venture Partners, and Pix Vine Capital.","partners":null,"customers":null,"investors":["Yehuda and Prof. Nava Zisapel","Sapir Venture Partners","Pix Vine Capital"],"confidence":9,"key_topics":["Synthetic biology","Vaccines","Investment","Partners"],"date_of_event":"November 6, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.7 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"oSj6k3rognCegaQ468hj9dO0tXGS7sUinqvg0p8JZH6UmTmcJOmM4s","news_summary":"Israeli viral vaccines co SynVaccine raises $1.7m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":1,"techcommunityinvolvement":null,"mediagallery":[{"id":"f1fad866-a233-42f2-ae64-d3d2d5d47a93","timestamp":"2017-07-03 06:19:26.000000","resources_type":2,"resources_title":"","resources_file_name":"nBbj6pM3AwU","alt":"","imageurl":"https://img.youtube.com/vi/nBbj6pM3AwU/0.jpg","url":"http://youtu.be/nBbj6pM3AwU"}],"tags":["pharmaceuticals","viral-diseases","bioinformatics","vaccines-development","disease-management","genomics","animal-health","laboratories","vaccines","bioconvergence"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":[{"date":"2013-07-01","name":"CAD/CAM for designing and fabricating designer viruses for biotechnology","tags":["viral-diseases","bioinformatics","genomics"],"category":"Pharmaceuticals & Diagnostics","tto_logo":"/image_cloud/ramot_tto_logo_f01045b8-6016-11e8-8e45-41fdcbb0dda7","university_logo":"/image_cloud/ramot_institution_logo_f01045b8-6016-11e8-8e45-41fdcbb0dda6"},{"date":"2013-07-01","name":"Design and synthesis of viral-based therapeutics","tags":["pharmaceuticals","viral-diseases","genomics","bioinformatics","vaccines"],"category":"Pharmaceuticals & Diagnostics","tto_logo":"/image_cloud/yeda_tto_logo_fbd2f2eb-6016-11e8-8318-41fdcbb0dda6","university_logo":"/image_cloud/yeda_institution_logo_fbd2f2eb-6016-11e8-8318-41fdcbb0dda6"}],"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":["SynRAD"],"geomarkets":["Israel"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":6,"lastfunding":"$1.7M","totalrounds":2,"fundingstage":"Seed","totalfunding":"$1.76M","publicinvestors":6,"lastpublicfunding":1700000,"totalpublicrounds":2,"totalpublicfunding":1756000},"team":[{"name":"Tamir Tuller","email":"tamirtul@post.tau.ac.il","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGn_ZAIDA","bounced":false,"claimed":0,"founder":1,"urlname":"tamir-tuller-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8aiCmAgM","position":"Co-Founder & CSO","last_name":"Tuller","claimtoken":"ea1735a3bd4f7efc941355e36b8f9d680aef79e0036367fe6bcfc2e117f51891","first_name":"Tamir","picturekey":"$QerGO3I500dlNApiCr2cFIHQZtknXRQbeMvLKuEpWpLOOgJkylBTvg","claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tamir-tuller-9620991/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-20 19:40:15.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$QerGO3I500dlNApiCr2cFIHQZtknXRQbeMvLKuEpWpLOOgJkylBTvg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tuval  Ben Yehezkel","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPz-jIcJDA","bounced":false,"claimed":0,"founder":1,"urlname":"tuval-ben-yehezkel-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgvOGZyQoM","position":"Co-founder (No longer with the company)","last_name":"Ben Yehezkel","claimtoken":"bd7897d38973646d7341898a3a51fd4fe670c58d3d0315ee8e8a79ec426bccfa","first_name":"Tuval ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/tuval-ben-yehezkel-04608424/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-04-06 10:19:44.000000","initials":"TB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Modi Roopin","email":"modi@synvaccine.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJmjj_oKDA","bounced":true,"claimed":0,"founder":0,"urlname":"modi-roopin","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg2fKyhgsM","position":"Head of R&D; Molecular Virology","last_name":"Roopin","claimtoken":"044f93ed463a7977f71f493b562f1e7a182aab7fee59c331fd28492fd0c6a30b","first_name":"Modi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/modiroopin/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-20 19:40:14.000000","initials":"MR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Avner  Finger, DVM","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPPXoY4JDA","bounced":false,"claimed":0,"founder":0,"urlname":"avner-finger-dvm","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgq_S9hwkM","position":"Animal Vaccines BD","last_name":"Finger, DVM","claimtoken":"4be941bba17885b3ac4b3b757369b8aba3880edddccd6af6dcceae0dbaae4f99","first_name":"Avner ","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-04-06 10:19:38.000000","initials":"AF","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-04-07T00:00:00.000Z","crunchbaseid":"syn-vaccine","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-12-31T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Natalia Golczar","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjY_BCgw","date":"Nov 2017","amount":"$1.7M","source":"Migrated + https://en.globes.co.il/en/article-israeli-viral-vaccines-co-synvaccine-raises-17m-1001210612 + silent round project","eventtype":"FundingRoundEvent","investment":[{"name":"A2Z Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Singapore","fullurl":"/investor_page/a2z-venture-partners","logokey":null,"tagline":"","urlname":"/investor_page/a2z-venture-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCko8SNCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7954680a-42b8-462c-9e7a-5d66582fd5a4","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Pix Vine Capital","type":"Investor","amount":0,"hidden":false,"country":"Singapore","fullurl":"/investor_page/pix-vine-capital","logokey":"$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","tagline":null,"urlname":"/investor_page/pix-vine-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7V_Z8LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"afb0b413-32cb-4995-b56d-5fde28ce966f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Yehuda Zisapel (Late)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/yehuda-zisapel-late","logokey":"$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","tagline":null,"urlname":"/investor_page/yehuda-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKCh6OIIDA","fundingtype":"Angel","leadpartner":null,"investmentid":"dfc34cca-9654-4a29-9d0b-8484c7760a9d","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Nava Zisapel","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nava-zisapel","logokey":"$GZFkwcEs0fVHHiuGyFtfJYEgtHEXtaDLQeShwTSQ0BC8oTMCYvcF3r","tagline":"","urlname":"/investor_page/nava-zisapel","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODE1YPvCww","fundingtype":"Angel","leadpartner":null,"investmentid":"e8d7b856-26e7-4876-a372-0980d04c73ef","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GZFkwcEs0fVHHiuGyFtfJYEgtHEXtaDLQeShwTSQ0BC8oTMCYvcF3r","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ecbb17f6-d4a1-4870-be81-4b5a9a6c7f40","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"RAD BioMed","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/radbiomed","logokey":"$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","tagline":null,"urlname":"/investor_page/radbiomed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKOh2oAKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"iJRyzlZ7dSvAGV17TdIxMWfTTOkDZqJXRUaw8bceGZgHXYz1xS43lL","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":1700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2urfCgw","date":"Jun 2017","amount":"$56K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"EU Horizon 2020","type":"Other","amount":0,"hidden":false,"country":"Belgium","fullurl":"/company_page/eu-horizon-2020","logokey":"$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","tagline":"","urlname":"/company_page/eu-horizon-2020","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7vSzCgw","fundingtype":"Other","leadpartner":null,"investmentid":"3070bd55-f851-4800-9791-87f29230fe2b","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":56000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"7/2013","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"SynVaccine","logourl":"https://storage.googleapis.com/clean-finder-353810/$lYTlGquH3g75Il9klCzbtPomsTPKVanOJscPNfWoRiDWXxdECw6ytA","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$lYTlGquH3g75Il9klCzbtPomsTPKVanOJscPNfWoRiDWXxdECw6ytA","seoabout":"SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology. The company utilizes a multidisciplinary appr...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drugs Discovery & Development#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Drugs Discovery & Development","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drugs Discovery & Development"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"},{"title":"Biotechnology","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drugs Discovery & Development","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety_cIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Drugs Discovery & Development"],"coreTechnology":["Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEjY_BCgw","date":"Nov 2017","amount":"$1.7M","source":"Migrated + https://en.globes.co.il/en/article-israeli-viral-vaccines-co-synvaccine-raises-17m-1001210612 + silent round project","eventtype":"FundingRoundEvent","investment":[{"name":"A2Z Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Singapore","fullurl":"/investor_page/a2z-venture-partners","logokey":null,"tagline":"","urlname":"/investor_page/a2z-venture-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCko8SNCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"7954680a-42b8-462c-9e7a-5d66582fd5a4","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Pix Vine Capital","type":"Investor","amount":0,"hidden":false,"country":"Singapore","fullurl":"/investor_page/pix-vine-capital","logokey":"$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","tagline":null,"urlname":"/investor_page/pix-vine-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7V_Z8LDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"afb0b413-32cb-4995-b56d-5fde28ce966f","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$yS4CvF4Ymgk830cXl4tUixJibuI1LKGABP047LoTXA8WQc8GnhvPI7","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Yehuda Zisapel (Late)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/yehuda-zisapel-late","logokey":"$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","tagline":null,"urlname":"/investor_page/yehuda-zisapel-late","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoKCh6OIIDA","fundingtype":"Angel","leadpartner":null,"investmentid":"dfc34cca-9654-4a29-9d0b-8484c7760a9d","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$prsLqopz8iSzcD7p6TNH3y8QKZHax5QiJP0qCdeJPbivJOKxaaJP4l","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Nava Zisapel","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nava-zisapel","logokey":"$GZFkwcEs0fVHHiuGyFtfJYEgtHEXtaDLQeShwTSQ0BC8oTMCYvcF3r","tagline":"","urlname":"/investor_page/nava-zisapel","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODE1YPvCww","fundingtype":"Angel","leadpartner":null,"investmentid":"e8d7b856-26e7-4876-a372-0980d04c73ef","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$GZFkwcEs0fVHHiuGyFtfJYEgtHEXtaDLQeShwTSQ0BC8oTMCYvcF3r","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ecbb17f6-d4a1-4870-be81-4b5a9a6c7f40","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"RAD BioMed","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/radbiomed","logokey":"$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","tagline":null,"urlname":"/investor_page/radbiomed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKOh2oAKDA","fundingtype":"Incubator","leadpartner":null,"investmentid":"iJRyzlZ7dSvAGV17TdIxMWfTTOkDZqJXRUaw8bceGZgHXYz1xS43lL","fundingsubtype":"Incubator","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8Q5Rwt22LKpRes13ZNTxXwFNiOfEKKujTG6u7PIRBDQr1KJWlllXfv","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":1700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2urfCgw","date":"Jun 2017","amount":"$56K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"EU Horizon 2020","type":"Other","amount":0,"hidden":false,"country":"Belgium","fullurl":"/company_page/eu-horizon-2020","logokey":"$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","tagline":"","urlname":"/company_page/eu-horizon-2020","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE7vSzCgw","fundingtype":"Other","leadpartner":null,"investmentid":"3070bd55-f851-4800-9791-87f29230fe2b","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Y11JsXnB1FT2S0h1lyXUQMAhH6bM0g2tSIdWQAjTFxivAoweBwRj4g","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":56000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}